Illumina Inc Q1 2025 Earnings Report

Illumina Inc, a life sciences tools and services company, has released its Q1 2025 earnings report. Key highlights from the announcement include:

• Revenue and earnings guidance were revised due to macroeconomic pressures.
• The company reported strong cash flow generation.
• An innovation pipeline is in place to drive future growth.

Stock Price Performance

• The stock price has declined by 5.4% over the past few days following an analyst downgrade.
• The stock price has been volatile, ranging from a high of $156.66 to a low of $68.7 over the past year.
• The current stock price is lower than the 52-week high.

Market Capitalization and Valuation

• The company’s market capitalization is approximately $12.11 billion USD.
• The price-to-earnings ratio is negative at -9.95, indicating potential undervaluation.